RSV/Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSV/Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older [Phase 1]